Taipei Exchange - Delayed Quote TWD
TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
9.41
-0.04
(-0.42%)
At close: 1:30:34 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
150,651
150,651
123,134
36,230
1,294,522
Cost of Revenue
16,132
16,132
11,448
3,736
12,720
Gross Profit
134,519
134,519
111,686
32,494
1,281,802
Operating Expense
256,617
256,617
286,385
310,164
382,344
Operating Income
-122,098
-122,098
-174,699
-277,670
899,458
Net Non Operating Interest Income Expense
22,976
22,976
19,245
7,869
3,985
Pretax Income
-32,885
-32,885
143,487
-229,765
875,991
Tax Provision
5,698
5,698
6,756
7,399
100,373
Net Income Common Stockholders
-38,583
-38,583
136,731
-237,164
775,618
Diluted NI Available to Com Stockholders
-38,583
-38,583
136,731
-237,164
775,618
Basic EPS
-0.05
--
0.19
-0.33
1.08
Diluted EPS
-0.05
--
0.19
-0.33
1.08
Basic Average Shares
771,660
--
719,636.84
716,844
716,844
Diluted Average Shares
771,660
--
719,636.84
716,844
717,363
Total Expenses
272,749
272,749
297,833
313,900
395,064
Net Income from Continuing & Discontinued Operation
-38,583
-38,583
136,731
-237,164
775,618
Normalized Income
-47,851
-47,851
-20,710.67
-227,755.20
775,622.43
Interest Income
24,400
24,400
20,382
8,723
4,229
Interest Expense
1,424
1,424
1,137
854
244
Net Interest Income
22,976
22,976
19,245
7,869
3,985
EBIT
-31,461
-31,461
144,624
-228,911
876,235
EBITDA
-6,632
-6,632
172,230
-200,366
905,099
Reconciled Cost of Revenue
16,132
16,132
11,448
3,736
12,720
Reconciled Depreciation
24,829
24,829
27,606
28,545
28,864
Net Income from Continuing Operation Net Minority Interest
-38,583
-38,583
136,731
-237,164
775,618
Total Unusual Items Excluding Goodwill
11,585
11,585
165,221
-11,761
-5
Total Unusual Items
11,585
11,585
165,221
-11,761
-5
Normalized EBITDA
-18,217
-18,217
7,009
-188,605
905,104
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
2,317
2,317
7,779.33
-2,352.20
-0.57
12/31/2021 - 8/30/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4168.TWO GlycoNex Incorporation
16.10
+0.31%
4167.TWO Savior Lifetec Corporation
17.85
+0.85%
3176.TWO Medigen Biotechnology Corp.
28.90
+0.70%
4726.TWO Mycenax Biotech Inc.
30.55
-0.81%
4174.TWO OBI Pharma, Inc.
42.20
-9.93%
4743.TWO Oneness Biotech Co., Ltd.
60.30
-1.63%
4162.TWO PharmaEngine, Inc.
87.70
+0.34%
4147.TWO TaiMed Biologics Inc.
79.60
-1.24%
4142.TW Adimmune Corporation
18.15
-2.68%
4130.TWO Genovate Biotechnology Co., Ltd.
20.15
0.00%